Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.350
+0.060 (2.62%)
Oct 28, 2025, 1:31 PM EDT - Market open

Cardiff Oncology Statistics

Total Valuation

CRDF has a market cap or net worth of $156.34 million. The enterprise value is $86.23 million.

Market Cap156.34M
Enterprise Value 86.23M

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025, after market close.

Earnings Date Oct 29, 2025
Ex-Dividend Date n/a

Share Statistics

CRDF has 66.53 million shares outstanding. The number of shares has increased by 30.91% in one year.

Current Share Class 66.53M
Shares Outstanding 66.53M
Shares Change (YoY) +30.91%
Shares Change (QoQ) +0.00%
Owned by Insiders (%) 2.45%
Owned by Institutions (%) 44.23%
Float 64.90M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 245.97
Forward PS 397.26
PB Ratio 2.60
P/TBV Ratio 2.66
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 158.22
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.42, with a Debt / Equity ratio of 0.02.

Current Ratio 4.42
Quick Ratio 4.29
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -91.93% and return on invested capital (ROIC) is -59.56%.

Return on Equity (ROE) -91.93%
Return on Assets (ROA) -47.90%
Return on Invested Capital (ROIC) -59.56%
Return on Capital Employed (ROCE) -91.98%
Revenue Per Employee $16,515
Profits Per Employee -$1.55M
Employee Count33
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -19.08% in the last 52 weeks. The beta is 1.62, so CRDF's price volatility has been higher than the market average.

Beta (5Y) 1.62
52-Week Price Change -19.08%
50-Day Moving Average 2.17
200-Day Moving Average 3.12
Relative Strength Index (RSI) 53.81
Average Volume (20 Days) 871,152

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, CRDF had revenue of $545,000 and -$51.04 million in losses. Loss per share was -$0.87.

Revenue545,000
Gross Profit -40.86M
Operating Income -54.33M
Pretax Income -51.02M
Net Income -51.04M
EBITDA -53.95M
EBIT -54.33M
Loss Per Share -$0.87
Full Income Statement

Balance Sheet

The company has $70.96 million in cash and $1.19 million in debt, giving a net cash position of $69.77 million or $1.05 per share.

Cash & Cash Equivalents 70.96M
Total Debt 1.19M
Net Cash 69.77M
Net Cash Per Share $1.05
Equity (Book Value) 58.61M
Book Value Per Share 0.88
Working Capital 57.03M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$41.85 million and capital expenditures -$26,000, giving a free cash flow of -$41.87 million.

Operating Cash Flow -41.85M
Capital Expenditures -26,000
Free Cash Flow -41.87M
FCF Per Share -$0.63
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -9,969.17%
Pretax Margin -9,361.28%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRDF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -30.91%
Shareholder Yield -30.91%
Earnings Yield -32.72%
FCF Yield -26.84%

Analyst Forecast

The average price target for CRDF is $11.10, which is 372.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target $11.10
Price Target Difference 372.34%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 172.98%
EPS Growth Forecast (5Y) 10.92%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on February 20, 2019. It was a reverse split with a ratio of 1:6.

Last Split Date Feb 20, 2019
Split Type Reverse
Split Ratio 1:6

Scores

CRDF has an Altman Z-Score of -2.61 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.61
Piotroski F-Score 1